ORODISPERSIBLE TABLETS MARKET ANALYSIS

Orodispersible Tablets Market, By Drug Class (Analgesics, Antiemetics, Antipsychotics, Anti-inflammatory Drugs, Sedatives/Hypnotics, Antihypertensives, Others), By Disease Indication (Central Nervous System Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Respiratory Disorders, Allergy and Asthma, Others), By Age Group (Pediatric Patients, Adult Patients, Geriatric Patients), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Nov 2023
Code : CMI5745
Pages :160
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Companies covered:

AstraZeneca PLC, GlaxoSmithKline PLC, Novartis International AG, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Pfizer Inc., Cipla Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Inc., Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Eisai Co., Ltd., Takeda Pharmaceutical Company Limited

Top companies in Global Orodispersible Tablets Market